Bashir Jaffer
Keine laufenden Positionen mehr
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Daniel E. Stryker | M | - |
Veridicom International, Inc.
 Veridicom International, Inc. Packaged SoftwareTechnology Services Veridicom International, Inc. provides biometric authentication and identity management solutions. These solutions are built on proprietary and patented hardware products, software solution and algorithms. The company offers the only complete 'out-of-the-box' identity management solution, integrating hardware and core enterprise middleware and application software into one seamless authentication suite. Identity management solutions are used in government, defense, enterprise, industry and matters of Homeland Security. The company was founded on September 9, 1987 and is headquartered in Verona, NJ. | 19 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Hassan Salari | M | 69 |
Chemokine Therapeutics Corp.
 Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 9 Jahre |
| Ryan Cheung | M | 45 |
The Institute of Chartered Accountants of British Columbia
| 5 Jahre |
| Dennis William Mee | M | 80 |
The Institute of Chartered Accountants of British Columbia
| - |
| David Fynn | M | 67 |
The Institute of Chartered Accountants of British Columbia
| - |
| Laird G. Branham | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Donald CK Wong | M | - |
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | - |
| Donald J. A. Smith | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Annette Cusworth | F | - |
The Institute of Chartered Accountants of British Columbia
| 20 Jahre |
| John R. Ellen | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Reza Bahadori | M | 53 |
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 1 Jahre |
| Bernard Clinton Byrd | M | 61 |
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | - |
| Larry Yau | M | 60 |
The Institute of Chartered Accountants of British Columbia
| - |
| Barry Swanson | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Paul Leslie Hammond | M | 75 |
The Institute of Chartered Accountants of British Columbia
| - |
| Larry D. Sorenson | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Adam Kniec | M | 54 |
The Institute of Chartered Accountants of British Columbia
| - |
| Calvin Mah | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Douglas Penrose | M | 76 |
The Institute of Chartered Accountants of British Columbia
| 35 Jahre |
| Michael Allen Evans | M | 64 |
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 3 Jahre |
| Adrian Rothwell | M | 53 |
The Institute of Chartered Accountants of British Columbia
| - |
| Jeff Redmond | M | 52 |
The Institute of Chartered Accountants of British Columbia
| - |
| Paul Zhang | M | 55 |
The Institute of Chartered Accountants of British Columbia
| - |
| Sze Wan Wong | F | 50 |
The Institute of Chartered Accountants of British Columbia
| - |
| Terry Eyton | M | 78 |
The Institute of Chartered Accountants of British Columbia
| - |
| Gordon K. W. Gee | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Trish Saltys | F | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Patricia A. McIver | F | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Jeremy Sundin | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Warwick Bay | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| John Webster | M | 69 |
The Institute of Chartered Accountants of British Columbia
| - |
| Dan Kriznic | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Gregory Smith | M | - |
The Institute of Chartered Accountants of British Columbia
| 9 Jahre |
| Pak Ying Mak | M | 65 |
The Institute of Chartered Accountants of British Columbia
| 21 Jahre |
| Darren Urquhart | M | 50 |
The Institute of Chartered Accountants of British Columbia
| 12 Jahre |
| John Parker | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Kevin Grayston | M | 68 |
The Institute of Chartered Accountants of British Columbia
| 6 Jahre |
| John Downes | M | 48 |
The Institute of Chartered Accountants of British Columbia
| 7 Jahre |
| Kwan In Li | M | 72 |
The Institute of Chartered Accountants of British Columbia
| - |
| David G. Goold | M | 69 |
The Institute of Chartered Accountants of British Columbia
| 30 Jahre |
| Max Liszkowski | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Bernie Zacharias | M | 45 |
The Institute of Chartered Accountants of British Columbia
| - |
| John Parkinson | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Nigel Fripp | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Michael Clark | M | 42 |
The Institute of Chartered Accountants of British Columbia
| - |
| Robert Elton | M | 72 |
The Institute of Chartered Accountants of British Columbia
| - |
| Mahesh Liyanage | M | 52 |
The Institute of Chartered Accountants of British Columbia
| - |
| Mark A. Campbell | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Susan Rubin | F | 70 |
The Institute of Chartered Accountants of British Columbia
| - |
| Giovanni N. Susin | M | - |
The Institute of Chartered Accountants of British Columbia
| 19 Jahre |
| Martin Bajic | M | 47 |
The Institute of Chartered Accountants of British Columbia
| - |
| Limor Rubin Shtanger | F | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Philip J. Walsh | M | - |
The Institute of Chartered Accountants of British Columbia
| 41 Jahre |
| Hon Cheung So | M | 68 |
The Institute of Chartered Accountants of British Columbia
| 28 Jahre |
| Alistair Duncan | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Ralph Proceviat | M | 73 |
The Institute of Chartered Accountants of British Columbia
| - |
| Graham Thody | M | 73 |
The Institute of Chartered Accountants of British Columbia
| 37 Jahre |
| Thomas S. Chambers | M | 79 |
The Institute of Chartered Accountants of British Columbia
| - |
| Raymond Polman | M | 64 |
The Institute of Chartered Accountants of British Columbia
| - |
| Pieter de Visser | M | 74 |
The Institute of Chartered Accountants of British Columbia
| - |
| Ichiang Cheng | M | 70 |
The Institute of Chartered Accountants of British Columbia
| - |
| Gordon E. Cummings | M | 56 |
The Institute of Chartered Accountants of British Columbia
| - |
| Jeffrey Mason | M | 67 |
The Institute of Chartered Accountants of British Columbia
| 3 Jahre |
| Dennis E. Petke | M | 60 |
The Institute of Chartered Accountants of British Columbia
| 18 Jahre |
| David P. Hall | M | 76 |
The Institute of Chartered Accountants of British Columbia
| - |
| Peter Meredith | M | 80 |
The Institute of Chartered Accountants of British Columbia
| 31 Jahre |
| Mohammad Azab | M | 68 |
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 1 Jahre |
| Keith E. Steeves | M | 91 |
The Institute of Chartered Accountants of British Columbia
| - |
| Brian Kuhn | M | - |
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | - |
| Kenneth W. McArthur | M | 88 |
The Institute of Chartered Accountants of British Columbia
| - |
| Frederick Vandenberg | M | 54 |
The Institute of Chartered Accountants of British Columbia
| - |
| William Grossholz | M | 67 |
The Institute of Chartered Accountants of British Columbia
| - |
| Robert Adrian Biagioni | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Jacquelyn Susan Glazer | F | 48 |
The Institute of Chartered Accountants of British Columbia
| - |
| Michael Sweatman | M | 73 |
The Institute of Chartered Accountants of British Columbia
| 21 Jahre |
| Thomas Sitar | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Simon Anderson | M | 62 |
The Institute of Chartered Accountants of British Columbia
| - |
| Leonard J. Cox | M | 52 |
The Institute of Chartered Accountants of British Columbia
| - |
| Patrick Groening | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Stephen Tucker | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Edward Renyk | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| John Mason | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Mannie Druker | M | - |
The Institute of Chartered Accountants of British Columbia
| 33 Jahre |
| Anthony L. Soda | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Reginald J. Labonte | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Foo Chan | M | 68 |
The Institute of Chartered Accountants of British Columbia
| - |
| Michael Heskin | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Larry Johnson | M | - |
The Institute of Chartered Accountants of British Columbia
| 16 Jahre |
| Derek John Robert Brodie | M | 79 |
The Institute of Chartered Accountants of British Columbia
| - |
| Victor de Bonis | M | - |
The Institute of Chartered Accountants of British Columbia
| 20 Jahre |
| Steven Michael Blacklock | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| Kenneth Ian Matheson | M | 82 |
The Institute of Chartered Accountants of British Columbia
| - |
| Don Sharp | M | 78 |
The Institute of Chartered Accountants of British Columbia
| - |
| Douglas Eacrett | M | 78 |
The Institute of Chartered Accountants of British Columbia
| - |
| Hamish Malkin | M | 77 |
The Institute of Chartered Accountants of British Columbia
| - |
| Richard L. Richards | M | - |
The Institute of Chartered Accountants of British Columbia
| 48 Jahre |
| Guy Ely | M | 71 |
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 1 Jahre |
| Robert Miller | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| J. McKinney | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
| David Warren | M | - |
The Institute of Chartered Accountants of British Columbia
| - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Kanada | 99 | 99,00% |
| Vereinigte Staaten | 1 | 1,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Bashir Jaffer
- Persönliches Netzwerk
